News
Following the completion of this acquisition, Bristol-Myers Squibb will enter into a collaborative agreement with AstraZeneca, in order to develop and commercialise Amylin’s existing portfolio ...
AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 21,865.00 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback